These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2433464)

  • 1. Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus.
    Stapleton JT; Lemon SM
    J Virol; 1987 Feb; 61(2):491-8. PubMed ID: 2433464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus.
    Ping LH; Jansen RW; Stapleton JT; Cohen JI; Lemon SM
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8281-5. PubMed ID: 2460866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies.
    Ping LH; Lemon SM
    J Virol; 1992 Apr; 66(4):2208-16. PubMed ID: 1312628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles.
    Stapleton JT; Raina V; Winokur PL; Walters K; Klinzman D; Rosen E; McLinden JH
    J Virol; 1993 Feb; 67(2):1080-5. PubMed ID: 7678298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against hepatitis A virus.
    MacGregor A; Kornitschuk M; Hurrell JG; Lehmann NI; Coulepis AG; Locarnini SA; Gust ID
    J Clin Microbiol; 1983 Nov; 18(5):1237-43. PubMed ID: 6315771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.
    Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F
    J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
    Highlander SL; Sutherland SL; Gage PJ; Johnson DC; Levine M; Glorioso JC
    J Virol; 1987 Nov; 61(11):3356-64. PubMed ID: 2444713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites.
    Marlin SD; Holland TC; Levine M; Glorioso JC
    J Virol; 1985 Jan; 53(1):128-36. PubMed ID: 2578193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1.
    Silberstein E; Dveksler G; Kaplan GG
    J Virol; 2001 Jan; 75(2):717-25. PubMed ID: 11134285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants.
    McCahon D; Crowther JR; Belsham GJ; Kitson JD; Duchesne M; Have P; Meloen RH; Morgan DO; De Simone F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():639-45. PubMed ID: 2471793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A.
    Delem A; Safary A; De Namur F; Hauser P; D'Hondt E
    Vaccine; 1993; 11(4):479-84. PubMed ID: 8385844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies.
    Li C; Li W; Lucio de Esesarte E; Guo H; van den Elzen P; Aarts E; van den Born E; Rottier PJM; Bosch BJ
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.
    Fiore L; Ridolfi B; Genovese D; Buttinelli G; Lucioli S; Lahm A; Ruggeri FM
    J Virol; 1997 Sep; 71(9):6905-12. PubMed ID: 9261417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site.
    Hughes JV; Stanton LW; Tomassini JE; Long WJ; Scolnick EM
    J Virol; 1984 Nov; 52(2):465-73. PubMed ID: 6208377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies.
    Elder JH; McGee JS; Munson M; Houghten RA; Kloetzer W; Bittle JL; Grant CK
    J Virol; 1987 Jan; 61(1):8-15. PubMed ID: 2431166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Location of immunodominant antigenic determinants on fragments of the tick-borne encephalitis virus glycoprotein: evidence for two different mechanisms by which antibodies mediate neutralization and hemagglutination inhibition.
    Heinz FX; Berger R; Tuma W; Kunz C
    Virology; 1983 Oct; 130(2):485-501. PubMed ID: 6196909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against an immunodominant and neutralizing epitope on hepatitis A virus antigen.
    Crevat D; Crance JM; Chevrinais AM; Passagot J; Biziagos E; Somme G; Deloince R
    Arch Virol; 1990; 113(1-2):95-8. PubMed ID: 1696807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.